QQQ   420.51 (-0.68%)
AAPL   165.35 (-1.01%)
MSFT   400.89 (-0.84%)
META   490.29 (-2.29%)
GOOGL   154.81 (-0.77%)
AMZN   176.92 (-1.28%)
TSLA   149.38 (-0.37%)
NVDA   828.45 (-2.16%)
AMD   151.96 (-2.01%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   110.40 (-1.37%)
GE   152.07 (-0.57%)
CGC   8.07 (+3.07%)
DIS   112.17 (-0.23%)
AMC   3.06 (+4.79%)
PFE   25.47 (+0.32%)
PYPL   61.99 (-0.18%)
XOM   120.40 (+1.59%)
QQQ   420.51 (-0.68%)
AAPL   165.35 (-1.01%)
MSFT   400.89 (-0.84%)
META   490.29 (-2.29%)
GOOGL   154.81 (-0.77%)
AMZN   176.92 (-1.28%)
TSLA   149.38 (-0.37%)
NVDA   828.45 (-2.16%)
AMD   151.96 (-2.01%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   110.40 (-1.37%)
GE   152.07 (-0.57%)
CGC   8.07 (+3.07%)
DIS   112.17 (-0.23%)
AMC   3.06 (+4.79%)
PFE   25.47 (+0.32%)
PYPL   61.99 (-0.18%)
XOM   120.40 (+1.59%)
QQQ   420.51 (-0.68%)
AAPL   165.35 (-1.01%)
MSFT   400.89 (-0.84%)
META   490.29 (-2.29%)
GOOGL   154.81 (-0.77%)
AMZN   176.92 (-1.28%)
TSLA   149.38 (-0.37%)
NVDA   828.45 (-2.16%)
AMD   151.96 (-2.01%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   110.40 (-1.37%)
GE   152.07 (-0.57%)
CGC   8.07 (+3.07%)
DIS   112.17 (-0.23%)
AMC   3.06 (+4.79%)
PFE   25.47 (+0.32%)
PYPL   61.99 (-0.18%)
XOM   120.40 (+1.59%)
QQQ   420.51 (-0.68%)
AAPL   165.35 (-1.01%)
MSFT   400.89 (-0.84%)
META   490.29 (-2.29%)
GOOGL   154.81 (-0.77%)
AMZN   176.92 (-1.28%)
TSLA   149.38 (-0.37%)
NVDA   828.45 (-2.16%)
AMD   151.96 (-2.01%)
NIO   3.87 (-3.25%)
BABA   68.81 (-0.10%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   110.40 (-1.37%)
GE   152.07 (-0.57%)
CGC   8.07 (+3.07%)
DIS   112.17 (-0.23%)
AMC   3.06 (+4.79%)
PFE   25.47 (+0.32%)
PYPL   61.99 (-0.18%)
XOM   120.40 (+1.59%)
Free Trial

Kiora Pharmaceuticals (KPRX) News Today

→ Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad)
Free KPRX Stock Alerts
$0.50
-0.01 (-1.75%)
(As of 09:41 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media
SourceHeadline
MarketBeat logoKiora Pharmaceuticals (NASDAQ:KPRX) Trading Down 7.9%
americanbankingnews.com - April 18 at 1:52 AM
msn.com logoKiora Pharmaceuticals reports FY results
msn.com - March 25 at 3:18 PM
markets.businessinsider.com logoKiora Pharmaceuticals: Strong Buy Rating on Strategic Partnership and Promising Trial Results
markets.businessinsider.com - February 9 at 2:42 PM
markets.businessinsider.com logoHC Wainwright & Co. Maintains Buy Rating for Kiora Pharmaceuticals: Here's What You Need To Know
markets.businessinsider.com - February 9 at 2:42 PM
msn.com logoWhat's Going On With Kiora Pharmaceuticals Stock?
msn.com - February 1 at 4:26 PM
benzinga.com logoWhy Nextracker Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
benzinga.com - February 1 at 8:44 AM
msn.com logoWhy Is Kiora Pharmaceuticals (KPRX) Stock Up 39% Today?
msn.com - February 1 at 8:44 AM
msn.com logoKiora stock soars after hours on deal with Thea Open Innovation
msn.com - January 31 at 7:54 PM
finance.yahoo.com logoKiora Pharmaceuticals and Théa Open Innovation Enter Strategic Agreement to Develop and Commercialize KIO-301 for the Treatment of Inherited Retinal Diseases; Total Deal Value of up to $301 Million includes $16 Million Upfront, up to $285 Million in Clinical Development, Regulatory and Commercial Milestones, Plus Commercial Royalties
finance.yahoo.com - January 31 at 7:53 PM
finance.yahoo.com logoKiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
finance.yahoo.com - January 31 at 7:53 PM
marketbeat.com logo
marketbeat.com - January 31 at 5:10 PM
morningstar.com logoKiora Pharmaceuticals Inc KPRX
morningstar.com - January 9 at 1:14 PM
finance.yahoo.com logoBreaking ground in vision restoration: Kiora Pharmaceuticals reveals promising results with KIO-301
finance.yahoo.com - November 17 at 2:44 PM
benzinga.com logoKiora Pharmaceuticals Stock (NASDAQ:KPRX) Earnings Dates and Earning Calls
benzinga.com - November 11 at 7:29 PM
msn.com logoKiora Pharmaceuticals reports Q3 results
msn.com - November 9 at 9:22 AM
finance.yahoo.com logoKiora Pharmaceuticals Reports Q3 2023 Results; Expanding Clinical Development of KIO-301 for Inherited Retinal Diseases Based on Encouraging Results of ABACUS-1 Study in Retinitis Pigmentosa
finance.yahoo.com - November 9 at 9:22 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Cassava Sciences (SAVA), Kiora Pharmaceuticals (KPRX) and Bluebird Bio (BLUE)
markets.businessinsider.com - November 8 at 12:35 AM
markets.businessinsider.com logoAnalyst Expectations for Kiora Pharmaceuticals's Future
markets.businessinsider.com - November 6 at 7:03 PM
finance.yahoo.com logoAAO Late-Breaking: Kiora's Small Molecule Photoswitch Demonstrates Meaningful Vision Improvements in Blind Patients with Retinitis Pigmentosa
finance.yahoo.com - November 4 at 12:21 PM
finance.yahoo.com logoKiora Pharmaceuticals to Participate in the Lytham Partners Fall 2023 Investor Conference
finance.yahoo.com - October 16 at 10:40 AM
finance.yahoo.com logoKiora Pharmaceuticals Receives Investigational New Drug Application Approval to Expand Phase 1b Study of KIO-301 in Inherited Retinal Diseases; To Enroll Patients with Choroideremia and Additional Patients with Late-Stage Retinitis Pigmentosa
finance.yahoo.com - October 3 at 9:41 AM
finance.yahoo.com logoKiora Pharmaceuticals Appoints Praveen Tyle, PhD, as New Chairman; Succeeds Paul Chaney Who is Retiring After Serving 17 Years
finance.yahoo.com - September 21 at 8:05 AM
finance.yahoo.com logoKiora Pharmaceuticals Completes Last Patient, Last Visit in Phase 1B Trial of KIO-301 in Patients with Retinitis Pigmentosa
finance.yahoo.com - September 18 at 8:35 AM
finance.yahoo.com logoKiora Pharmaceuticals to Present Topline Results from the ABACUS Study at American Academy Ophthalmology (AAO); Phase 1b Study Evaluating KIO-301 in Retinitis Pigmentosa
finance.yahoo.com - September 14 at 10:02 AM
finance.yahoo.com logoKiora Pharmaceuticals Adjourns Special Meeting of Stockholders to September 27
finance.yahoo.com - September 1 at 9:40 AM
finance.yahoo.com logoKiora Pharmaceuticals and the Choroideremia Research Foundation to Host Webinar on the Development of Molecular Photoswitches for Inherited Retinal Diseases
finance.yahoo.com - August 29 at 5:13 PM
finance.yahoo.com logoIs Kiora Pharmaceuticals Significantly Undervalued? A Comprehensive Valuation Analysis
finance.yahoo.com - August 24 at 1:09 PM
marketwatch.com logoKiora Pharmaceuticals Shares Up 18% on Patents Covering Ocular Delivery of Molecules
marketwatch.com - August 23 at 3:20 PM
markets.businessinsider.com logoWhy Is Kiora Pharmaceuticals (KPRX) Stock Up 11% Today?
markets.businessinsider.com - August 23 at 10:14 AM
finance.yahoo.com logoKiora Pharmaceuticals Granted U.S. and European Patents for Local Ocular Delivery of the KIO-100 Family of Compounds; New IP Specifically Includes Treatment of Posterior Non-Infectious Uveitis
finance.yahoo.com - August 23 at 10:14 AM
finance.yahoo.com logoKiora Pharmaceuticals Taps B2i Digital to Deploy Data-Driven Investor Awareness Program
finance.yahoo.com - August 22 at 5:34 PM
finance.yahoo.com logoKiora Pharmaceuticals Webcasts Its Investor Presentation from the H.C. Wainwright 3rd Annual Ophthalmology Virtual Conference
finance.yahoo.com - August 16 at 8:46 AM
finance.yahoo.com logoKiora Pharmaceuticals Announces Q2 2023 Earnings and Business Update, Highlighting Pipeline Updates and Clinical Development Progress
finance.yahoo.com - August 8 at 11:07 AM
finance.yahoo.com logoKiora Pharmaceuticals, Inc. and Choroideremia Research Foundation Partner to Advance Novel Choroideremia Treatment
finance.yahoo.com - August 3 at 10:12 AM
finance.yahoo.com logoBiotech Leader Carmine Stengone Joins Kiora Pharmaceuticals' Board of Directors
finance.yahoo.com - August 1 at 6:35 PM
investorplace.com logoWhy Is Kiora Pharmaceuticals (KPRX) Stock Down 7% Today?
investorplace.com - July 21 at 9:08 AM
finanznachrichten.de logoKiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Receives $1.2 Million in Research Tax Credits to Advance the Treatment of Ophthalmic Disease
finanznachrichten.de - July 5 at 8:54 AM
finance.yahoo.com logoKiora Pharmaceuticals Receives $1.2 Million in Research Tax Credits to Advance the Treatment of Ophthalmic Disease
finance.yahoo.com - July 5 at 8:54 AM
marketwatch.com logo8-K: KIORA PHARMACEUTICALS INC
marketwatch.com - June 22 at 6:32 PM
finance.yahoo.com logoLife Science Investor Forum Agenda Announced for June 22nd
finance.yahoo.com - June 20 at 11:23 AM
finanznachrichten.de logoKiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals and Sentrx Animal Care Amend Existing Manufacturing Licensing Agreement for KIO-201
finanznachrichten.de - June 15 at 7:43 AM
finance.yahoo.com logoKiora Pharmaceuticals and Sentrx Animal Care Amend Existing Manufacturing Licensing Agreement for KIO-201
finance.yahoo.com - June 15 at 7:43 AM
finance.yahoo.com logoKiora Pharmaceuticals to Present at Upcoming Investor Conferences
finance.yahoo.com - June 14 at 10:07 AM
finance.yahoo.com logoKiora Pharmaceuticals Announces Closing of $6.3 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
finance.yahoo.com - June 6 at 7:32 PM
baystreet.ca logoKiora Heralds Public Offering
baystreet.ca - June 2 at 12:36 PM
investorplace.com logoWhy Is Kiora Pharmaceuticals (KPRX) Stock Down 49% Today?
investorplace.com - June 2 at 10:09 AM
msn.com logoRecap: Kiora Pharmaceuticals Q1 Earnings
msn.com - May 9 at 3:03 PM
finance.yahoo.com logoKiora Pharmaceuticals Reports First Quarter Results; Positive Clinical Data Driving Significant Progress Advancing Pipeline of Eye Disease Treatments
finance.yahoo.com - May 9 at 10:02 AM
finance.yahoo.com logoKiora Pharmaceuticals Presents Encore Imaging Results of KIO-301 for Retinitis Pigmentosa at ASNR 2023 Meeting
finance.yahoo.com - May 1 at 7:50 AM
finance.yahoo.com logoKiora's Investigational Treatment for Retinitis Pigmentosa, KIO-301, Demonstrates Visual Function Restoration in Patients Who Are Blind
finance.yahoo.com - April 27 at 6:43 PM
Get Kiora Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for KPRX and its competitors with MarketBeat's FREE daily newsletter.

The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

KPRX Media Mentions By Week

KPRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

KPRX
News Sentiment
▼
0.59

0.52
▲
Average
Medical
News Sentiment

KPRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

KPRX Articles
This Week
▼
1

1
▲
KPRX Articles
Average Week

Get Kiora Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for KPRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:KPRX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
How Biden has already won 2024
Porter & Company
Urgent alert: open this for a huge profit potential
Timothy Sykes
My biggest AI fear
Paradigm Press